文献速递炎症性肠病

老年炎症性肠病轻度内镜活动与不良结局相关

Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease.
PubMed 文献 · Aliment Pharmacol Ther · 2025-10-15

本研究回顾性分析504例≥60岁炎症性肠病(IBD)患者,内镜下轻度活动者占38.1%,内镜缓解者占61.9%。多变量分析显示,轻度内镜活动与1年IBD特异性不良结局(aOR 4.16,95%CI 2.10-8.24)及1年发病率相关事件(aOR 1.56,95%CI 1.01-2.43)风险升高相关,且IBD特异性风险持续至5年。

要点

  • 老年IBD患者内镜轻度活动者1年IBD特异性不良结局风险显著高于内镜缓解者。
  • 轻度内镜活动亦与1年总体发病率相关事件风险轻度升高相关。
  • IBD特异性不良结局风险在5年时仍持续存在。

核心结论

  • 在老年IBD患者中,与内镜缓解相比,轻度内镜疾病活动与1年IBD特异性及发病率相关不良结局风险升高相关,且IBD特异性风险持续至5年。

研究设计与样本

  • 回顾性研究纳入504例≥60岁、2018年1月1日至2023年1月1日内镜检查示轻度或无疾病活动的IBD患者,中位病程11年。

主要发现

  • 192例(38.1%)患者为轻度内镜疾病活动,312例(61.9%)为内镜缓解。
  • 多变量分析显示,轻度内镜活动增加1年IBD特异性不良结局风险(aOR 4.16,95%CI 2.10-8.24),5年结果相似。
  • 轻度内镜活动增加1年发病率相关事件风险(aOR 1.56,95%CI 1.01-2.43)。

临床怎么用

  • 对老年IBD患者应重视实现内镜缓解,因其可能带来短期和长期获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The benefits of achieving endoscopic remission among older adults with inflammatory bowel disease (IBD) who have mild persistent disease activity are unknown. METHODS: This was a retrospective study of adults ≥ 60 with IBD who had mild or no disease activity on endoscopy from January 1, 2018-January 1, 2023. The primary outcome was a composite of major IBD-specific adverse events (hospitalizations, surgery, and prescription of corticosteroids for IBD-related symptoms) within 1 year of endoscopic assessment. Our secondary outcome was a composite of 1-year morbidity-related events (mortality, all-cause hospitalization, infection requiring antibiotics, venous thromboembolism, cardiovascular events, and osteoporotic fractures). We also assessed outcomes at 5 years. RESULTS: Among 504 patients, 192 (38.1%) had mild endoscopic disease and 312 (61.9%) were in endoscopic remission, with a median disease duration of 11 years. On multivariable analysis, mild endoscopic disease activity increased the odds of a 1-year adverse IBD-specific outcome (aOR 4.16, 95% CI 2.10-8.24), with similar results at 5 years. Furthermore, mild endoscopic disease was associated with increased odds of experiencing an adverse morbidity-related outcome within 1 year as compared to endoscopic remission (aOR 1.56, 95% CI 1.01-2.43). CONCLUSIONS: Among older adults with prevalent IBD, mild endoscopic disease activity, as compared to endoscopic remission, was associated with increased odds of adverse IBD-specific and morbidity-related outcomes at 1 year, with this risk persisting for IBD-specific outcomes at 5 years. These findings highlight the importance of achieving endoscopic remission, which may confer both short- and longer-term benefits in this population.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Tang CZ, Delau OR, Katz S, et al. Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease. Aliment Pharmacol Ther. 2025. PMID: 41090496. doi:10.1111/apt.70414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。